Brusatol, an NRF2 inhibitor for future cancer therapeutic

Overview of attention for article published in Cell & Bioscience, June 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 2,206 followers.

RT @cancerSL: Brusatol, an NRF2 inhibitor for future cancer therapeutic. https://t.co/K0b8vGXaKh

@lrandle_ljmu

RT @cancerSL: Brusatol, an NRF2 inhibitor for future cancer therapeutic. https://t.co/K0b8vGXaKh

Brusatol, an NRF2 inhibitor for future cancer therapeutic. https://t.co/K0b8vGXaKh

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.